Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn D Richardson

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Cancer Therapeutics|July 11, 2007
Novel antagonists of the thioesterase domain of human fatty acid synthaseRobyn D Richardson, Jeffrey W Smith
Plos One|September 24, 2014
3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systemsAmy L Howes, Robyn D Richardson, Darren Finlay, et al.
The Journal of Organic Chemistry|June 6, 2006
Practical, catalytic, asymmetric synthesis of beta-lactones via a sequential ketene dimerization/hydrogenation process: inhibitors of the thioesterase domain of fatty acid synthaseVikram C Purohit, Robyn D Richardson, Jeffrey W Smith, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2008
Beta-lactam congeners of orlistat as inhibitors of fatty acid synthaseWei Zhang, Robyn D Richardson, Supakarn Chamni, et al.
Plos One|October 23, 2010
Novel HTS strategy identifies TRAIL-sensitizing compounds acting specifically through the caspase-8 apoptotic axisDarren Finlay, Robyn D Richardson, Lisa K Landberg, et al.
Organic Letters|September 22, 2006
Total synthesis and comparative analysis of orlistat, valilactone, and a transposed orlistat derivative: Inhibitors of fatty acid synthaseGil Ma, Manuel Zancanella, Yatsandra Oyola, et al.
Organic Letters|May 5, 2006
Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activityColin G Ferguson, Cleve S Bigman, Robyn D Richardson, et al.
Journal of Medicinal Chemistry|August 20, 2008
Synthesis of novel beta-lactone inhibitors of fatty acid synthaseRobyn D Richardson, Gil Ma, Yatsandra Oyola, et al.
Bioorganic & Medicinal Chemistry|February 26, 2017
A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybridsMingzhao Zhu, Wayne D Harshbarger, Omar Robles, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Cancer Therapeutics|July 11, 2007
Novel antagonists of the thioesterase domain of human fatty acid synthaseRobyn D Richardson, Jeffrey W Smith
Plos One|September 24, 2014
3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systemsAmy L Howes, Robyn D Richardson, Darren Finlay, et al.
The Journal of Organic Chemistry|June 6, 2006
Practical, catalytic, asymmetric synthesis of beta-lactones via a sequential ketene dimerization/hydrogenation process: inhibitors of the thioesterase domain of fatty acid synthaseVikram C Purohit, Robyn D Richardson, Jeffrey W Smith, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2008
Beta-lactam congeners of orlistat as inhibitors of fatty acid synthaseWei Zhang, Robyn D Richardson, Supakarn Chamni, et al.
Plos One|October 23, 2010
Novel HTS strategy identifies TRAIL-sensitizing compounds acting specifically through the caspase-8 apoptotic axisDarren Finlay, Robyn D Richardson, Lisa K Landberg, et al.
Organic Letters|September 22, 2006
Total synthesis and comparative analysis of orlistat, valilactone, and a transposed orlistat derivative: Inhibitors of fatty acid synthaseGil Ma, Manuel Zancanella, Yatsandra Oyola, et al.
Organic Letters|May 5, 2006
Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activityColin G Ferguson, Cleve S Bigman, Robyn D Richardson, et al.
Journal of Medicinal Chemistry|August 20, 2008
Synthesis of novel beta-lactone inhibitors of fatty acid synthaseRobyn D Richardson, Gil Ma, Yatsandra Oyola, et al.
Bioorganic & Medicinal Chemistry|February 26, 2017
A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybridsMingzhao Zhu, Wayne D Harshbarger, Omar Robles, et al.
Pageof 1